home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
A2 BIO TO HIGHLIGHT PROGRAM UPDATES IN TWO PRESENTATIONS AT SITC 2021
A2 BIO TO HIGHLIGHT PROGRAM UPDATES IN TWO PRESENTATIONS AT SITC 2021
Post navigation
Previous Post
Previous
Theseus Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for THE-630, a Pan-Variant KIT Inhibitor in Development for the Treatment of Gastrointestinal Stromal Tumors (GIST)
Next Post
Next
Kinnate Biopharma Inc. in Collaboration with Guardant Health Announces Initial Findings from BRAF Kinase Alteration Genomic Landscape and Real-World Clinical Outcomes Study